- Date: January 09, 2020
Having completed four diverse and fruitful weeks of training, the 2019 CaixaImpulse Validate projects are now set to implement their valorisation plans.
These plans bring greater value to the projects, thus accelerating the speed at which they can reach the market and benefit society. The participants detail a plan of action which can include a proof of concept, as well as how they will address areas such as intellectual property, business development, and marketing.
Developed throughout the second half of 2019 and with the guidance of dedicated programme mentors, it was the assessment of these valorisation plans by an expert panel that determined how much additional funding each project would receive to carry them out.
In addition, participants can continue meeting with their assigned mentors and requesting up to twelve hours of consultancy with the programme’s directory of over 80 biomedical innovation experts, to help steer them in the right direction while executing their plans.
Former participants regularly cite this access to such a diverse community of industry players as an indispensable stepping stone in their project’s journey towards the market. You can discover some of their stories by visiting our programme highlights.
More programme highlights
March 18, 2020
These projects, which offer solutions to unmet biomedical needs, will each receive up to €300,000 to bring their asset to an investment-ready stage.
February 28, 2020
On the occasion of World Rare Disease Day, we spoke with Rubén Artero and Beatriz Llamusí, who form part of the former CaixaImpulse 2017 project MBNL.
February 20, 2020
Over five years of the programme, 103 projects have been supported, 20 of which are now spin-offs.